Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems

Journal of Hepatology

Volumn 64, Issue 3, 2016, Pages 601-608

  Liu, Po Hong ^a,b   Hsu, Chia Yang ^b,c   Hsia, Cheng Yuan ^a,b   Lee, Yun Hsuan ^a,b   Su, Chien Wei ^a,b   Huang, Yi Hsiang ^a,b   Lee, Fa Yauh ^a,b   Lin, Han Chieh ^a,b   Huo, Teh Ia ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatocellular carcinoma; Prognosis; Staging system; Treatment strategy

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; BILIRUBIN; CREATININE; SERUM ALBUMIN;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; ASCITES; ASSESSMENT OF HUMANS; CANCER OF THE LIVER ITALIAN PROGRAM SCORE; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; TREATMENT DURATION; TUMOR INVASION; LIVER TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84958830764     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.10.029     Document Type: Article

References (40)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 23/08/2015.
2. H.B. El-Serag Hepatocellular carcinoma N Engl J Med 365 2011 1118 1127
3. S. Subramaniam, R.K. Kelley, and A.P. Venook A review of hepatocellular carcinoma (HCC) staging systems Chin Clin Oncol 2 2013 33
4. J.A. Marrero, R.J. Fontana, A. Barrat, F. Askari, H.S. Conjeevaram, G.L. Su, and et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort Hepatology 41 2005 707 716
5. J.M. Llovet, C. Bru, and J. Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 1999 329 338
6. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 2012 908 943
7. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
8. T. Yau, V.Y. Tang, T.J. Yao, S.T. Fan, C.M. Lo, and R.T. Poon Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma Gastroenterology 146 2014 e1693
9. X. Adhoute, G. Penaranda, J.P. Bronowicki, and J.L. Raoul Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohort J Hepatol 62 2015 492 493
10. L.H. Sobin, and C.C. Compton TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer Cancer 116 2010 5336 5339
11. A. Kinoshita, H. Onoda, N. Fushiya, K. Koike, H. Nishino, and H. Tajiri Staging systems for hepatocellular carcinoma: Current status and future perspectives World J Hepatol 7 2015 406 424
12. C.Y. Hsu, Y.H. Huang, C.Y. Hsia, C.W. Su, H.C. Lin, C.C. Loong, and et al. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System J Hepatol 53 2010 108 117
13. K. Okuda, H. Obata, Y. Nakajima, T. Ohtsuki, N. Okazaki, and K. Ohnishi Prognosis of primary hepatocellular carcinoma Hepatology 4 1984 3S 6S
14. S. Chevret, J.C. Trinchet, D. Mathieu, A.A. Rached, M. Beaugrand, and C. Chastang A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire J Hepatol 31 1999 133 141
15. T.W. Leung, A.M. Tang, B. Zee, W.Y. Lau, P.B. Lai, K.L. Leung, and et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients Cancer 94 2002 1760 1769
16. M. Kudo, H. Chung, and Y. Osaki Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score) J Gastroenterol 38 2003 207 215
17. R. Tateishi, H. Yoshida, S. Shiina, H. Imamura, K. Hasegawa, T. Teratani, and et al. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients Gut 54 2005 419 425
18. M. Minagawa, I. Ikai, Y. Matsuyama, Y. Yamaoka, and M. Makuuchi Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan Ann Surg 245 2007 909 922
19. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients Hepatology 28 1998 751 755
20. J. Chapiro, and J.F. Geschwind Hepatocellular carcinoma: have we finally found the ultimate staging system for HCC? Nat Rev Gastroenterol Hepatol 11 2014 334 336
21. J. Bruix, M. Sherman, J.M. Llovet, M. Beaugrand, R. Lencioni, A.K. Burroughs, and et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
22. J. Bruix, and M. Sherman Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
23. W.Y. Kao, C.W. Su, G.Y. Chau, W.Y. Lui, C.W. Wu, and J.C. Wu A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery World J Surg 35 2011 858 867
24. G.Y. Chau Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome World J Gastroenterol 20 2014 12473 12484
25. Y.H. Huang, C.H. Chen, T.T. Chang, S.C. Chen, J.H. Chiang, H.S. Lee, and et al. The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stage Aliment Pharmacol Ther 21 2005 687 694
26. P.H. Liu, C.Y. Hsu, C.Y. Hsia, Y.H. Lee, Y.H. Huang, Y.Y. Chiou, and et al. Surgical resection versus radiofrequency ablation for single hepatocellular carcinoma
27. C.D. Fuller, S.J. Wang, M. Choi, B.G. Czito, J. Cornell, T.M. Welzel, and et al. Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis Cancer 115 2009 5175 5183
28. M.A. Pourhoseingholi, E. Hajizadeh, B. Moghimi Dehkordi, A. Safaee, A. Abadi, and M.R. Zali Comparing Cox regression and parametric models for survival of patients with gastric carcinoma Asian Pac J Cancer Prev 8 2007 412 416
29. J.G. Ibrahim, H. Chu, and M.H. Chen Missing data in clinical studies: issues and methods J Clin Oncol 30 2012 3297 3303
30. C.Y. Hsu, Y.H. Lee, C.Y. Hsia, Y.H. Huang, C.W. Su, H.C. Lin, and et al. Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system Hepatology 57 2013 112 119
31. P.J. Johnson, S. Berhane, C. Kagebayashi, S. Satomura, M. Teng, H.L. Reeves, and et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade J Clin Oncol 33 2015 550 558
32. P.H. Liu, Y.H. Lee, C.Y. Hsia, C.Y. Hsu, Y.H. Huang, Y.Y. Chiou, and et al. Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis Ann Surg Oncol 21 2014 1825 1833
33. C. Tournoux-Facon, X. Paoletti, J.C. Barbare, O. Bouche, P. Rougier, L. Dahan, and et al. Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting J Hepatol 54 2011 108 114
34. G. Torzilli, J. Belghiti, N. Kokudo, T. Takayama, L. Capussotti, G. Nuzzo, and et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group Ann Surg 257 2013 929 937
35. B. Franssen, K. Alshebeeb, P. Tabrizian, J. Marti, E.S. Pierobon, N. Lubezky, and et al. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center Ann Surg 260 2014 650 656 Discussion 656-658
36. C.Y. Hsu, Y.H. Lee, P.H. Liu, C.Y. Hsia, Y.H. Huang, H.C. Lin, and et al. Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model PLoS One 9 2014 e89373
37. T. Utsunomiya, M. Shimada, M. Kudo, T. Ichida, O. Matsui, N. Izumi, and et al. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients Ann Surg 261 2015 513 520
38. S. Ueno, G. Tanabe, K. Sako, T. Hiwaki, H. Hokotate, Y. Fukukura, and et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program Hepatology 34 2001 529 534
39. I. Levy, M. Sherman Liver Cancer Study Group of the University of Toronto Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto Gut 50 2002 881 885
40. F. Farinati, M. Rinaldi, S. Gianni, and R. Naccarato How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system Cancer 89 2000 2266 2273